PTX3, pentraxin 3, 5806

N. diseases: 296; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.080 AlteredExpression disease BEFREE Compared with the control group, the CAD group displayed significantly higher serum levels of retinol-binding protein-4 (RBP4), pentraxin 3 (PTX3), galectin-3 (GAL-3), and plasminogen activator inhibitor (PAI-1), and significantly lower levels of netrin-1 (NTN1), interleukin-37 (IL-37), and adiponectin (ADP) (all P < 0.05). 31464731 2019
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.080 AlteredExpression disease BEFREE However, elevated pentraxin-3 level appeared to not significantly increase the risk of cardiac events (RR 1.63; 95% CI 0.71-3.72) in stable CAD subgroup. 30954865 2019
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.080 Biomarker disease BEFREE In CAD (-) groups (Groups 3 and 4), PISA has shown positive correlations with PTX3 and SAA (p<0.05). 29742255 2018
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.080 Biomarker disease BEFREE Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease. 28946774 2018
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.080 AlteredExpression disease BEFREE Plasma pentraxin-3 and serum LDL, HDL, and high-sensitivity CRP levels were measured in 163 SAP and 28 non-coronary artery disease (CAD) patients. 29789902 2018
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.080 AlteredExpression disease BEFREE Stepwise multiple linear regression analysis showed that PTX3 levels and NLR levels were independently associated with CAD (r=1.3, P<0.05; r=1.8, P<0.05). 28778748 2017
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.080 AlteredExpression disease BEFREE Through this study design, the results could not support the hypothesis that adding EPA in patients with stable CAD receiving varying degrees of statin treatment reduces the plasma PTX3 level comprehensively. 27778191 2017
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.080 Biomarker disease BEFREE This paper is focused on the inherent effects of pentraxin 3 in inflammatory responses, mainly in coronary artery disease and in Aspergillus fumigatus infection. 22577258 2012